Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Clinical Trial of AZD2171 Monotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Patients

NCT00458978 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00458978 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Clinical Trial of AZD2171 Monotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Patients
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2007
Completion date
July 31, 2014
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent hypopharyngeal squamous cell carcinoma, recurrent laryngeal squamous cell carcinoma, recurrent laryngeal verrucous carcinoma, recurrent lip and oral cavity squamous cell carcinoma, recurrent metastatic squamous cell carcinoma in the neck with occult primary, recurrent nasal cavity and paranasal sinus squamous cell carcinoma, recurrent nasopharyngeal keratinizing squamous cell carcinoma, recurrent oral cavity verrucous carcinoma, recurrent oropharyngeal squamous cell carcinoma, recurrent salivary gland carcinoma, salivary gland squamous cell carcinoma, squamous cell carcinoma metastatic in the neck with occult primary, stage iv hypopharyngeal squamous cell carcinoma, stage iv laryngeal squamous cell carcinoma, stage iv laryngeal verrucous carcinoma, stage iv lip and oral cavity squamous cell carcinoma, stage iv major salivary gland carcinoma, stage iv nasal cavity and paranasal sinus squamous cell carcinoma, stage iv nasopharyngeal keratinizing squamous cell carcinoma, stage iv oral cavity verrucous carcinoma, stage iv oropharyngeal squamous cell carcinoma, tongue carcinoma, untreated metastatic squamous cell carcinoma to neck with occult primary